Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giacomo Boccuzzi

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Cardiology|September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registryFabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
European Journal of Preventive Cardiology|March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registryFabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Circulation. Cardiovascular Interventions|February 28, 2020
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis From the RAIN-CARDIOGROUP VII StudyLuca Gaido, Fabrizio D'Ascenzo, Yoichi Imori, et al.
The New England Journal of Medicine|April 29, 2020
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern ItalyOvidio De Filippo, Fabrizio D'Ascenzo, Filippo Angelini, et al.
International Journal of Cardiology|April 12, 2019
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)Carloalberto Biolè, Zenon Huczek, Ivan Nuñez-Gil, et al.
The American Journal of Cardiology|January 1, 2020
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary BifurcationsFabrizio D'Ascenzo, Umberto Barbero, Mohamed Abdirashid, et al.
Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
Heart (British Cardiac Society)|October 23, 2021
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closureLuis Marroquin, Gabriela Tirado-Conte, Radosław Pracoń, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Cardiology|September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registryFabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
European Journal of Preventive Cardiology|March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registryFabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Circulation. Cardiovascular Interventions|February 28, 2020
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis From the RAIN-CARDIOGROUP VII StudyLuca Gaido, Fabrizio D'Ascenzo, Yoichi Imori, et al.
The New England Journal of Medicine|April 29, 2020
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern ItalyOvidio De Filippo, Fabrizio D'Ascenzo, Filippo Angelini, et al.
International Journal of Cardiology|April 12, 2019
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)Carloalberto Biolè, Zenon Huczek, Ivan Nuñez-Gil, et al.
The American Journal of Cardiology|January 1, 2020
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary BifurcationsFabrizio D'Ascenzo, Umberto Barbero, Mohamed Abdirashid, et al.
Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
Heart (British Cardiac Society)|October 23, 2021
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closureLuis Marroquin, Gabriela Tirado-Conte, Radosław Pracoń, et al.
Pageof 10